We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
182 hedge funds and large institutions have $1.7B invested in Revance Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
163% more call options, than puts
Call options by funds: $239M | Put options by funds: $90.9M
133% more capital invested
Capital invested by funds: $731M → $1.7B (+$972M)
105% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 22
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
68% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 40
13% more funds holding
Funds holding: 161 → 182 (+21)
Holders
182
Holders Change
+21
Holders Change %
+13.04%
% of All Funds
3.14%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
45
Increased
67
Reduced
40
Closed
22
Calls
$239M
Puts
$90.9M
Net Calls
+$148M
Net Calls Change
+$147M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$70.2M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$27.3M |
| 3 |
Holocene Advisors
New York
|
+$21.6M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$17.3M |
| 5 |
Two Sigma Investments
New York
|
+$15.8M |
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$27.5M |
| 2 |
JP Morgan Chase
New York
|
-$25.1M |
| 3 |
Jennison Associates
New York
|
-$13.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.92M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.37M |
